European Commission – Antitrust: Commission fines Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine

European Commission Press release Brussels, 9 July 2014 The European Commission has imposed fines totalling €427.7 million on the French pharmaceutical company Servier and five producers of generic medicines – namely, Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin – for concluding a series of deals of deals… …read more Source: European Commission Competition Press Releases